Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH, Conference Calls/ Webcasts

Xenon Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference


BURNABY, British Columbia, April 21, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that it will host a company presentation at the 2023 Bloom Burton & Co. Healthcare Investor Conference to be held in Toronto, Ontario from April 25-26, 2023.

Company Presentation Details:
  
Date: Tuesday, April 25, 2023
  
Time:11:00 am Eastern Time (8:00 am Pacific Time)
  
Webcast:Register here
  
Presenter: Ian Mortimer, President and CEO

A live webcast of the company presentation will be available on the "Investors" section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

"Xenon" and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: [email protected]



These press releases may also interest you

at 06:30
Dhiraj Carumbaya joins ConcertAI as Senior Vice President and General Manager of TeraRecon
ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, today announced that Dhiraj Carumbaya has joined the company as Senior Vice President and General Manager of the...

at 06:05
Court Determines that Kurin Does Not Infringe Magnolia Medical Patent
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that Chief Judge Connolly of the U.S. District Court in Delaware issued an opinion in the patent litigation brought by Magnolia Medical, Inc. finding...

at 06:02
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS
SOPHiA GENETICS , a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDMtm Platform. The hospital will use SOPHiA...

at 06:00
Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development
Accenture has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that is building a platform for interpreting human biology. Accenture's investment will help Turbine further extend its capabilities...

at 06:00
M42 receives Global Healthcare Accreditation Certification for Excellence in Medical Travel Patient Experience
M42 has achieved the Global Healthcare Accreditation (GHA) certification for Excellence in Medical Travel Patient Experience from the US for its pioneering approach. With an overall score of 91 per cent, this certification reaffirms M42's commitment...

at 06:00
Justrite® Develops Groundbreaking Solution for the Growing Dangers of Lithium-Ion Battery Fires
In response to the critical need for safe storage and charging of lithium-ion batteries, Justrite announces the launch of its state-of-the-art Lithium-Ion Battery Charging Cabinet. Featuring the innovative 9-Layer ChargeGuardtm Containment System,...

More news about Health...


News published on and distributed by: